Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

SEMICYCLE

Financiado

Deciphering female’s SEx hormones - MIcrobiota interactions during a menstrual C...

Deciphering female’s SEx hormones - MIcrobiota interactions during a menstrual CYCLE for an efficient personalized medicine in cardiometabolic disorders Cardiometabolic disorders (CMD), a group of conditions that include cardiovascular diseases, type 2 diabetes and metabolic syndrome, are characterised by dysfunction of glycaemic and/or lipid metabolism. Clinical manifestations, s... ver más

30/04/2028

CNR

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

CONSIGLIO NAZIONALE DELLE RICERCHE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-23

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2022-STG: ERC STARTING GRANTS

I+D

Cerrada hace 2 años

0% 100% 100%

1 Participantes

CNR

1.50M€ | Lider

Proyectos interesantes

BES-2015-074480 ESTUDIO METABOLOMICO DE LA INTERACCION HUESPED-MICROBIOTA IN... 93K€ Cerrado

SAF2014-52875-R ESTUDIO METABOLOMICO DE LA INTERACCION HUESPED-MICROBIOTA IN... 194K€ Cerrado

HEROINE Hormone-microbiome interactions as a key-player in female he... 1M€ Cerrado

BFU2013-44229-R CARACTERIZACION DE NUEVAS RUTAS REGULADORAS DEL METABOLISMO... 266K€ Cerrado

PID2021-125104OB-I00 ESTUDIO DEL EFECTO PRODUCIDO POR LAS VESICULAS EXTRACELULARE... 157K€ Cerrado

RTI2018-102205-B-I00 MECANISMOS POR LOS QUE LA MICROBIOTA INTESTINAL PREVIENE EL... 121K€ Cerrado

Últimas noticias

02-12-2024: AGENCIA-VALENCIANA-D... En las últimas 48 horas el Organismo AGENCIA VALENCIANA D... ha otorgado 1 concesiones

02-12-2024: CDTI En las últimas 48 horas el Organismo CDTI ha otorgado 4 concesiones

01-12-2024: REDES En las últimas 48 horas el Organismo REDES ha otorgado 1337 concesiones

Duración del proyecto: 61 meses Fecha Inicio: 2023-03-23
Fecha Fin: 2028-04-30

Líder del proyecto

CONSIGLIO NAZIONALE DELLE RICERCHE

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto Cardiometabolic disorders (CMD), a group of conditions that include cardiovascular diseases, type 2 diabetes and metabolic syndrome, are characterised by dysfunction of glycaemic and/or lipid metabolism. Clinical manifestations, severity and progression are different between sexes, the underlying mechanisms of which are largely unknown. The poorer prognosis in women globally calls for an urgent need for better women’s tailored prevention and treatment strategies. Still, for an efficient personalised strategy, female-specific mechanisms have to be identified. The SEMICYCLE project will systematically investigate female’s sex hormones-microbiota interactions to unravel female-specific microbiota features regulating glycaemic and lipid metabolism in women during homeostasis and diseases. Findings of this research project will pinpoint key mechanisms useful to improve current prevention and diagnostic tools as well as therapeutic options of CMD. SEMICYCLE will follow up 300 healthy women during one menstrual cycle and longitudinal cross-omics data (five layers of information from host genome, gut microbiome, gut metabolome, vaginal microbiome, plasma proteome) will be generated, analysed and integrated with female sex hormones variations, lifestyle and diet, glycaemic and lipid phenotypes using state-of-the-art methodologies and computational approaches. Subsequently, mechanisms identified during homeostasis will be investigated for association with CMD onset and progression, using already existing cohorts totalling more than 10,000 samples. This research is based on my expertise and that of my research group in generating and analysing omics data in large data sets. Findings will reveal previously unknown microbiota regulators of CMD in women thus offering alternative routes for prevention, diagnosis and treatments in women, a necessary step for an efficient personalised medicine.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores